MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 6, 2014, Pages 2934-2941

  Yin, Bo ^a   Zeng, Yu ^a   Liu, Gang ^a   Wang, Xiaotian ^a   Wang, Peng ^a   Song, Yongsheng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

3 (MAGE A3); Bladder cancer; Cancer stem cells; Cancertestis; Immunotherapy; Melanoma antigen family a; Side population

Indexed keywords

MAGEA3 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ANIMAL; BIOSYNTHESIS; BLADDER TUMOR; CANCER STEM CELL; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SIDE POPULATION CELL; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIDE-POPULATION CELLS; URINARY BLADDER NEOPLASMS;

EID: 84904277599     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating so-cioeconomic and racial disparities on prema-ture cancer deaths. CA Cancer J Clin 2011; 61: 212-36.
2. Irani J, Mottet N, Ribal Caparros MJ, Teillac P. New Trends in Bladder Cancer Management. Eur Urol Suppl 2007; 6: 388-95.
3. Bentivegna A, Conconi D, Panzeri E, Sala E, Bovo G, Viganò P, Brunelli S, Bossi M, Tredici G, Strada G, Dalprà L. Biological heterogeneity of putative bladder cancer stem-like cell popula-tions from human bladder transitional cell car-cinoma samples. Cancer Sci 2010; 101: 416-24.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
5. Hirohashi Y, Torigoe T, Inoda S, Takahashi A, Morita R, Nishizawa S, Tamura Y, Suzuki H, Toyota M, Sato N. Immune response against tumor antigens expressed on human cancer stem-like cells/tumorinitiating cells. Immunotherapy 2010; 2: 201-11.
6. van der Horst G, Bos L, van der Pluijm G. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Mol Cancer Res 2012; 10: 995-1009.
7. She JJ, Zhang PG, Wang ZM, Gan WM, Che XM. Identiication of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biol Ther 2008; 7: 1663-8.
8. Yin B, Yang Y, Zhao Z, Zeng Y, Mooney SM, Li M, Xu X, Song Y, Wu B, Yang Z. Arachidonate 12-li-poxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells. Int J Oncol 2011; 38: 1041-6.
9. Gedye C, Quirk J, Browning J, Svobodová S, John T, Sluka P, Dunbar PR, Corbeil D, Cebon J, Davis ID. Cancer/testis antigens can be immu-nological targets in clonogenic CD133+ mela-noma cells. Cancer Immunol Immunother 2009; 58: 1635-46.
10. Inoda S, Hirohashi Y, Torigoe T, Morita R, Taka-hashi A, Asanuma H, Nakatsugawa M, Nishiza-wa S, Tamura Y, Tsuruma T, Terui T, Kondo T, Ishitani K, Hasegawa T, Hirata K, Sato N. Cyto-toxic T lymphocytes eficiently recognize hu-man colon cancer stem-like cells. Am J Pathol 2011; 178: 1805-13.
11. Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T, Kanaseki T, Kamiguchi K, Asanuma H, Morita R, Sokolovskaya A, Matsu-zaki J, Yamada R, Fujii R, Kampinga HH, Kondo T, Hasegawa T, Hara I, Sato N. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 2012; 72: 2844-54.
12. Miyazaki J, Nishiyama H, Yano I, Nakaya A, Ko-hama H, Kawai K, Joraku A, Nakamura T, Ha-rashima H, Akaza H. The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma. Anticancer Res 2011; 31: 2065-71.
13. Yin B, Liu G, Wang XS, Zhang H, Song YS, Wu B. Expression proile of cancer-testis genes in transitional cell carcinoma of the bladder. Urol Oncol 2012; 30: 886-92
14. Lonchay C, van der Bruggen P, Connerotte T, Hanagiri T, Coulie P, Colau D, Lucas S, Van Pel A, Thielemans K, van Baren N, Boon T. Correla-tion between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proc Natl Acad Sci U S A 2004; 101 Suppl 2: 14631-8
15. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 2004; 101: 781-6
16. Murase M, Kano M, Tsukahara T, Takahashi A, Torigoe T, Kawaguchi S, Kimura S, Wada T, Uchihashi Y, Kondo T, Yamashita T, Sato N. Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 2009; 101: 1425-32
17. Nakatsugawa M, Takahashi A, Hirohashi Y, To-rigoe T, Inoda S, Murase M, Asanuma H, Tamu-ra Y, Morita R, Michifuri Y, Kondo T, Hasegawa T, Takahashi H, Sato N. SOX2 is overexpressed in stem-like cells of human lung adenocarci-noma and augments the tumorigenicity. Lab Invest 2011; 91: 1796-804
18. Hadnagy A, Gaboury L, Beaulieu R, Balicki D. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006; 312: 3701-10
19. Soltanian S, Matin MM. Cancer stem cells and cancer therapy. Tumour Biol 2011; 32: 425-40
20. Rosenberg SA. A new era for cancer immuno-therapy based on the genes that encode can-cer antigens. Immunity 1999; 10: 281-7
21. Mori T, Nishizawa S, Hirohashi Y, Torigoe T, Tamura Y, Takahashi A, Kochin V, Fujii R, Kondo T, Greene MI, Hara I, Sato N. Eficiency of G2/M-related tumor-associated antigen-tar-geting cancer immunotherapy depends on an-tigen expression in the cancer stem-like popu-lation. Exp Mol Pathol 2012; 92: 27-32